NOUL unveils AI-powered miLab microscopy platform transforming point-of-care diagnostics
South Korean MedTech innovator NOUL has launched miLab™, an automated digital microscopy platform that promises to revolutionise diagnostic accessibility by bringing laboratory-grade analysis directly to resource-constrained clinical settings worldwide.
Integrated diagnostics breakthrough
The pioneering miLab system consolidates multiple diagnostic pathways – blood cell morphology, complete blood counts, malaria detection, and cervical cancer screening – into a single cartridge-based platform. This integration represents a significant advancement in point-of-care technology, combining smear preparation, Next-Generation Staining & Immunostaining (NGSI), and high-resolution imaging capabilities.
NOUL describes their innovation as bringing “gold-standard diagnostics to decentralised settings” through seamless automation that eliminates traditional laboratory constraints.
AI-driven precision eliminates human variability
The platform’s on-device artificial intelligence engine delivers both quantitative and qualitative results with unprecedented consistency. By removing the inherent variability of manual microscopy interpretation, miLab addresses a fundamental challenge in diagnostic accuracy across different operators and settings.
Digital slides become instantly accessible for remote expert consultation, enabling specialist oversight regardless of geographical barriers.
This connectivity transforms isolated healthcare facilities into nodes within a broader diagnostic network.
According to NOUL, miLab “empowers clinical labs to diagnose faster, more consistently, and more efficiently – anywhere in the world” by merging “the accuracy of traditional microscopy with the scalability of automation and AI.”
For more information, visit: https://noul.com/en
Digital issue: Please click here for more information
